Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial

Raychaudhuri R, DeJong M, Rettig M, Yu EY, Gulati R, Schweizer MT, Nelson PS, Pritchard CC, Montgomery B, Cheng HH. Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial. Eur Urol. 2024 Jun 17:S0302-2838(24)02407-2. doi: 10.1016/j.eururo.2024.05.025. Epub ahead of print. PMID: 38890069.


Related Posts